THE ROLE OF PDGF AND TSP-1 IN THE DEVELOPMENT OF SYSTEMIC SCLERODERMA

dc.contributor.authorAbdakimova Baxtigul Ilhomiddin qizi
dc.date.accessioned2025-12-29T17:59:37Z
dc.date.issued2025-07-20
dc.description.abstractSystemic scleroderma (SSc), also called systemic sclerosis, is a chronic autoimmune disease. It causes: - Thickening and hardening of the skin - Damage to small blood vessels - Fibrosis of internal organs (like lungs, heart, kidneys)
dc.formatapplication/pdf
dc.identifier.urihttps://webofjournals.com/index.php/5/article/view/4907
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/24817
dc.language.isoeng
dc.publisherWeb of Journals Publishing
dc.relationhttps://webofjournals.com/index.php/5/article/view/4907/4952
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWeb of Medicine: Journal of Medicine, Practice and Nursing ; Vol. 3 No. 7 (2025): WOM; 49-51
dc.source2938-3765
dc.subjectSystemic scleroderma, PDGF, TSP-1, fibrosis, angiogenesis, vascular damage, autoimmune disease, TGF-beta, fibroblasts, treatment.
dc.titleTHE ROLE OF PDGF AND TSP-1 IN THE DEVELOPMENT OF SYSTEMIC SCLERODERMA
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
qizi_2025_the_role_of_pdgf_and_tsp-1_in_the_develo.pdf
item.page.filesection.size
288.35 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections